Key facts
- Adamant Health’s last known valuation is $6.8M (Apr 2022).
- It has raised $7.3M; the latest was Later Stage VC ($1.2M) in Aug 2025.
- Notable investors include Business Finland, Nordic Mentor Network For Entrepreneurship, Cor Group, Gerresheimer, Instrumentarium Science Foundation — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Adamant Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Adamant Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Adamant Health
Developer of health and medical device technology designed to support patient-centric, on-demand care for Parkinson's disease and other movement disorders. The company offers a clinically used measurement and analysis service built on artificial intelligence, longitudinal patient data, and motion and muscle activity tracking, enabling hospitals, clinics, and research organizations to identify patients needing attention and optimize ongoing care decisions.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2020
- Employees
- 25
- Website
- adamanthealth.com/
- Ownership
- Privately Held (backing)
Adamant Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Adamant Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Adamant Health in its N-PORT filings yet. We sweep new filings monthly.